-
AstraZeneca's thyroid cancer drug launches
WILMINGTON, Del. — Anglo-Swedish drug maker AstraZeneca has made the drug vandetanib available to certain thyroid cancer patients.
The drug maker announced Monday that the drug would be available to patients with medullary thyroid cancer that could not be removed surgically or that had spread to other parts of the body. The Food and Drug Administration approved the drug on April 6, and it is available exclusively through the pharmacy business unit of Biologics Inc., an integrated cancer management company.
-
ShopRite adds dietitians, mobile spaces
ShopRite is striving to help its shoppers shop right by focusing on health and wellness and added convenience. To help customers live healthier lives, the grocer has, at select locations, an on-site registered dietitian.
Wakefern implemented the retail dietitian program in 2006, and today there are 20 retail dietitians working in 23 ShopRite locations.